Back to 
ING Groep N.V.
ING Groep N.V.
TEVA
Showing 0 of 7 quarters
Position history for ING Groep N.V.'s holdings in Teva Pharmaceutical Industries Limited
No. ING Groep exited its TEVA (Teva Pharmaceutical Industries) position in Q4 2023. Its Q3 2023 13F listed 1,600 shares worth $16,320. ING Groep already held TEVA in its Q1 2019 13F, the earliest on record, and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.